Cargando…
Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma
Multiple myeloma (MM) is largely incurable and drug-resistant. Novel therapeutic approaches such as inhibiting autophagy or rational drug combinations are aimed to overcome this issue. In this study, we found that lycorine exhibits a promising anti-proliferative activity against MM in vitro and in v...
Autores principales: | Roy, Mridul, Liang, Long, Xiao, Xiaojuan, Peng, Yuanliang, Luo, Yuhao, Zhou, Weihua, Zhang, Ji, Qiu, Lugui, Zhang, Shuaishuai, Liu, Feng, Ye, Mao, Zhou, Wen, Liu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135444/ https://www.ncbi.nlm.nih.gov/pubmed/27924158 http://dx.doi.org/10.7150/thno.15584 |
Ejemplares similares
-
Lycorine: A prospective natural lead for anticancer drug discovery
por: Roy, Mridul, et al.
Publicado: (2018) -
NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma
por: Xia, Jiliang, et al.
Publicado: (2020) -
Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy
por: Wang, Huiqiang, et al.
Publicado: (2019) -
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020) -
Solamargine induces autophagy‐mediated apoptosis and enhances bortezomib activity in multiple myeloma
por: Han, Qiaoyan, et al.
Publicado: (2022)